ArticleClinical pharmacology and therapeutics2019

Response to "Oral Chaperone Therapy Migalastat for the Treatment of Fabry Disease: Potentials and Pitfalls of Real-World Data".

Jonas Müntze et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.